Search
01/12/2021
Consensus on diagnosis and management of Cushing's disease: a guideline update
Fleseriu, M, Auchus, R, Bancos, I, Ben-Shlomo, A, Bertherat, J, Biermasz, NR, Boguszewski, CL, Bronstein, MD, Buchfelder, M, Carmichael, JD, Casanueva, FF, Castinetti, F, Chanson, P, Findling, J, Gadelha, M, Geer, EB, Giustina, A, Grossman, A, Gurnell, M, Ho, K, Ioachimescu, AG, Kaiser, UB, Karavitaki, N, Katznelson, L, Kelly, DF, Lacroix, A, McCormack, A, Melmed, S, Molitch, M, Mortini, P, Newell-Price, J, Nieman, L, Pereira, AM, Petersenn, S, Pivonello, R, Raff, H, Reincke, M, Salvatori, R, Scaroni, C, Shimon, I, Stratakis, CA, Swearingen, B, Tabarin, A, Takahashi, Y, Theodoropoulou, M, Tsagarakis, S, Valassi, E, Varlamov, EV, Vila, G, Wass, J, Webb, SM, Zatelli, MC, Biller, BMK. Consensus on diagnosis and management of Cushing's disease: a guideline update. Lancet Diabetes & Endocrinology. 2021; 9(12)DOI:10.1016/S2213-8587(21)00235-7. PMID:34687601. IF:44.867(Q1/1D).
01/12/2021
Serum miR-181b-5p predicts ascites onset in patients with compensated cirrhosis
de Paredes, AGG, Villanueva, C, Blanco, C, Genesca, J, Manicardi, N, Garcia-Pagan, JC, Calleja, JL, Aracil, C, Morillas, RM, Poca, M, Penas, B, Augustin, S, Abraldes, JG, Alvarado, E, Royo, F, Garcia-Bermejo, ML, Falcon-Perez, JM, Banares, R, Bosch, J, Gracia-Sancho, J, Albillos, A. Serum miR-181b-5p predicts ascites onset in patients with compensated cirrhosis. Jhep Reports. 2021; 3(6)DOI:10.1016/j.jhepr.2021.100368. PMID:34712934. IF:9.917(Q1/2D).
01/12/2021
A Large Multicenter Prospective Study of Community-Onset Healthcare Associated Bacteremic Urinary Tract Infections in the Era of Multidrug Resistance: Even Worse than Hospital Acquired Infections?
Gomez-Zorrilla, S, Becerra-Aparicio, F, Montesinos, IL, de Gopegui, ER, Grau, I, Pintado, V, Padilla, B, Benito, N, Boix-Palop, L, Farinas, MC, Penaranda, M, Gamallo, MR, Martinez, JA, Morte-Romea, E, Del Pozo, JL, Duran-Jorda, X, Diaz-Reganon, J, Lopez-Mendoza, D, Canton, R, Oliver, A, Ruiz-Garbajosa, P, Horcajada, JP. A Large Multicenter Prospective Study of Community-Onset Healthcare Associated Bacteremic Urinary Tract Infections in the Era of Multidrug Resistance: Even Worse than Hospital Acquired Infections?. Infectious Diseases and Therapy. 2021; 10(4)DOI:10.1007/s40121-021-00537-0. PMID:34626347. IF:6.119(Q2/3D).
01/12/2021
Oral Antibiotic Prophylaxis Lowers Surgical Site Infection in Elective Colorectal Surgery: Results of a Pragmatic Cohort Study in Catalonia
Badia, JM, Flores-Yelamos, M, Vazquez, A, Arroyo-Garcia, N, Puig-Asensio, M, Pares, D, Pera, M, Lopez-Contreras, J, Limon, E, Pujol, M. Oral Antibiotic Prophylaxis Lowers Surgical Site Infection in Elective Colorectal Surgery: Results of a Pragmatic Cohort Study in Catalonia. Journal of Clinical Medicine. 2021; 10(23)DOI:10.3390/jcm10235636. PMID:34884337. IF:4.964(Q2/4D).
01/12/2021
How to Handle Concomitant Asymptomatic Prosthetic Joints During an Episode of Hematogenous Periprosthetic Joint Infection, a Multicenter Analysis
Wouthuyzen-Bakker, M, Sebillotte, M, Arvieux, C, Fernandez-Sampedro, M, Senneville, E, Barbero, JM, Lora-Tamayo, J, Aboltins, C, Trebse, R, Salles, MJ, Kramer, TS, Ferrari, M, Garcia-Canete, J, Benito, N, Diaz-Brito, V, Del Toro, MD, Scarborough, M, Soriano, A. How to Handle Concomitant Asymptomatic Prosthetic Joints During an Episode of Hematogenous Periprosthetic Joint Infection, a Multicenter Analysis. CLINICAL INFECTIOUS DISEASES. 2021; 73(11)DOI:10.1093/cid/ciaa1222. PMID:32813012. IF:20.999(Q1/1D).
01/12/2021
Identification of Recent Tuberculosis Exposure Using QuantiFERON-TB Gold Plus, a Multicenter Study
Perez-Recio, S, Pallares, N, Grijota-Camino, MD, Sanchez-Montalva, A, Barcia, L, Campos-Gutierrez, S, Pomar, V, Rabunal-Rey, R, Balcells, ME, Gazel, D, Montiel, N, Vicente, D, Goic-Barisic, I, Schon, T, Paues, J, Marekovic, I, Cacho-Calvo, J, Barac, A, Goletti, D, Garcia-Gasalla, M, Barcala, JM, Tortola, MT, Anibarro, L, Suarez-Toste, I, Moga, E, Gude-Gonzalez, MJ, Naves, R, Karsligil, T, Martin-Penaranda, T, Stevanovic, G, Trigo, M, Rubio, V, Karaoglan, I, Bayram, N, Alcaide, F, Tebe, C, Santin, M. Identification of Recent Tuberculosis Exposure Using QuantiFERON-TB Gold Plus, a Multicenter Study. Microbiology Spectrum. 2021; 9(3)DOI:10.1128/Spectrum.00972-21. PMID:34756079. IF:9.043(Q1/2D).
01/12/2021
Bronchial Thermoplasty Global Registry (BTGR): 2-year results
Torrego, A, Herth, FJ, Munoz-Fernandez, AM, Puente, L, Facciolongo, N, Bicknell, S, Novali, M, Gasparini, S, Bonifazi, M, Dheda, K, Andreo, F, Votruba, P, Langton, D, Flandes, J, Fielding, D, Bonta, PI, Skowasch, D, Schulz, C, Darwiche, K, McMullen, E, Grubb, GM, Niven, R. Bronchial Thermoplasty Global Registry (BTGR): 2-year results. BMJ Open. 2021; 11(12)DOI:10.1136/bmjopen-2021-053854. PMID:34916324. IF:3.007(Q2/5D).
01/12/2021
Alpha variant SARS-CoV-2 infection: How it all starts
Domingo, P, de Benito, N. Alpha variant SARS-CoV-2 infection: How it all starts. EBioMedicine. 2021; 74DOI:10.1016/j.ebiom.2021.103703. PMID:34800902. IF:11.205(Q1/2D).
01/12/2021
First-line osimertinib in patients with epidermal growth factor receptor-mutant non-small-cell lung cancer and with a coexisting low allelic fraction of Thr790Met
Majem, M, Sullivan, I, Viteri, S, Lopez-Vivanco, G, Cobo, M, Sanchez, JM, Garcia-Gonzalez, J, Garde, J, Sampayo, M, Martrat, G, Malfettone, A, Karachaliou, N, Molina-Vila, MA, Rosell, R. First-line osimertinib in patients with epidermal growth factor receptor-mutant non-small-cell lung cancer and with a coexisting low allelic fraction of Thr790Met. EUROPEAN JOURNAL OF CANCER. 2021; 159DOI:10.1016/j.ejca.2021.09.039. PMID:34763195. IF:10.002(Q1/2D).
01/12/2021
Effector Mechanisms of CD8+HLA-DR+ T Cells in Breast Cancer Patients Who Respond to Neoadjuvant Chemotherapy
Osuna-Gomez, R, Arqueros, C, Galano, C, Mulet, M, Zamora, C, Barnadas, A, Vidal, S. Effector Mechanisms of CD8+HLA-DR+ T Cells in Breast Cancer Patients Who Respond to Neoadjuvant Chemotherapy. Cancers. 2021; 13(24)DOI:10.3390/cancers13246167. PMID:34944786. IF:6.575(Q1/3D).
01/12/2021
PD-L1 testing and clinical management of newly diagnosed metastatic non-small cell lung cancer in Spain: MOREL study
Rubio-Viqueira, B, Tarruella, MM, Lazaro, M, Estevez, SV, Cordoba-Ortega, JF, Maiques, IM, Gonzalez, JG, Cordellat, AB, Valdivia-Bautista, J, Arenas, CG, Torres, JMS. PD-L1 testing and clinical management of newly diagnosed metastatic non-small cell lung cancer in Spain: MOREL study. Lung Cancer Management. 2021; 10(4)DOI:10.2217/lmt-2021-0008. PMID:34899993. IF:(Q/D).
01/12/2021
Management of Localized Muscle-Invasive Bladder Cancer from a Multidisciplinary Perspective: Current Position of the Spanish Oncology Genitourinary (SOGUG) Working Group
Caamano, AG, Vicente, AMGM, Maroto, P, Antolin, AR, Sanz, J, Gonzalez, MAV, Climent, MA. Management of Localized Muscle-Invasive Bladder Cancer from a Multidisciplinary Perspective: Current Position of the Spanish Oncology Genitourinary (SOGUG) Working Group. Current Oncology. 2021; 28(6)DOI:10.3390/curroncol28060428. PMID:34940067. IF:3.109(Q3/8D).
01/12/2021
Immunotherapy-induced isolated ACTH deficiency in cancer therapy
Iglesias, P, Peiro, I, Biagetti, B, Paja-Fano, M, Cobo, DA, Gomez, CG, Mateu-Salat, M, Genua, I, Majem, M, Riudavets, M, Gavira, J, Lamas, C, Pombo, AF, Guerrero-Perez, F, Villabona, C, Agricola, JMC, Webb, SM, Diez, JJ. Immunotherapy-induced isolated ACTH deficiency in cancer therapy. ENDOCRINE-RELATED CANCER. 2021; 28(12)DOI:10.1530/ERC-21-0228. PMID:34609950. IF:5.905(Q1/3D).
01/12/2021
Efficacy of nintedanib plus docetaxel in patients with refractory advanced epidermal growth factor receptor mutant lung adenocarcinoma
Riudavets, M, Bosch-Barrera, J, Cabezon-Gutierrez, L, Tain, PD, Hernandez, A, Alonso, M, Blanco, R, Galvez, E, Insa, A, Mielgo, X, Moran, T, Ponce, S, Roa, D, Sanchez, JM, Majem, M. Efficacy of nintedanib plus docetaxel in patients with refractory advanced epidermal growth factor receptor mutant lung adenocarcinoma. Clinical & Translational Oncology. 2021; 23(12)DOI:10.1007/s12094-021-02661-2. PMID:34292495. IF:3.340(Q3/7D).
01/12/2021
A DNA damage repair gene-associated signature predicts responses of patients with advanced soft-tissue sarcoma to treatment with trabectedin
Moura, DS, Pena-Chilet, M, Varela, JAC, Alvarez-Alegret, R, Agra-Pujol, C, Izquierdo, F, Ramos, R, Ortega-Medina, L, Martin-Davila, F, Castilla-Ramirez, C, Hernandez-Leon, CN, Romagosa, C, Salgado, MAV, Lavernia, J, Bague, S, Mayodormo-Aranda, E, Vicioso, L, Barcelo, JEH, Rubio-Casadevall, J, de Juan, A, Fiano-Valverde, MC, Hindi, N, Lopez-Alvarez, M, Lacerenza, S, Dopazo, J, Gutierrez, A, Alvarez, R, Valverde, C, Martinez-Trufero, J, Martin-Broto, J. A DNA damage repair gene-associated signature predicts responses of patients with advanced soft-tissue sarcoma to treatment with trabectedin. Molecular Oncology. 2021; 15(12)DOI:10.1002/1878-0261.12996. PMID:33983674. IF:7.449(Q1/3D).
01/12/2021
Predictive Value of MRP-1 in Localized High-Risk Soft Tissue Sarcomas: A Translational Research Associated to ISG-STS 1001 Randomized Phase III Trial
Martin-Broto, J, Lopez-Alvarez, M, Moura, DS, Ramos, R, Collini, P, Romagosa, C, Bague, S, Renne, SL, Barisella, M, Velasco, V, Coindre, JM, Lopez-Lopez, D, Dopazo, J, Gambarotti, M, Braglia, L, Merlo, DF, Palmerini, E, Stacchiotti, S, Quagliuolo, VL, Lopez-Pousa, A, Grignani, G, Blay, JY, Brunello, A, Gutierrez, A, Valverde, C, Hindi, N, Dei Tos, AP, Picci, P, Casali, PG, Gronchi, A. Predictive Value of MRP-1 in Localized High-Risk Soft Tissue Sarcomas: A Translational Research Associated to ISG-STS 1001 Randomized Phase III Trial. MOLECULAR CANCER THERAPEUTICS. 2021; 20(12)DOI:10.1158/1535-7163.MCT-21-0315. PMID:34552008. IF:6.011(Q2/3D).
01/12/2021
Predictive value of transcriptional expression of Kruppel-like factor-6 (KLF6) in head and neck carcinoma patients treated with radiotherapy
Leon, X, Venegas, M, Pujol, A, Bulboa, C, Llansana, A, Casasayas, M, Quer, M, Camacho, M. Predictive value of transcriptional expression of Kruppel-like factor-6 (KLF6) in head and neck carcinoma patients treated with radiotherapy. Clinical & Translational Oncology. 2021; 23(12)DOI:10.1007/s12094-021-02651-4. PMID:34061320. IF:3.340(Q3/7D).
01/12/2021
Timing of elective tracheotomy and duration of mechanical ventilation among patients admitted to intensive care with severe COVID-19: A multicenter prospective cohort study
Prats-Uribe, A, Tobed, M, Villacampa, JM, Aguero, A, Garcia-Bastida, C, Tato, JI, Rodriganez, L, Holguera, VD, Hernandez-Garcia, E, Poletti, D, Simonetti, G, Villarraga, V, Meler-Claramonte, C, Barrueco, AS, Chiesa-Estomba, C, Casasayas, M, Parente-Arias, P, Mata-Castro, N, Rello, J, Castro, P, Prieto-Alhambra, D, Vilaseca, I, Aviles-Jurado, FX. Timing of elective tracheotomy and duration of mechanical ventilation among patients admitted to intensive care with severe COVID-19: A multicenter prospective cohort study. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK. 2021; 43(12)DOI:10.1002/hed.26863. PMID:34524714. IF:3.821(Q1/2D).
01/12/2021
An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis
Jimenez, AMJ, De Lima, M, Komanduri, KV, Wang, TP, Zhang, MJ, Chen, KR, Abdel-Azim, H, Abid, MB, Aljurf, M, Alkhateeb, H, Assal, A, Bacher, U, Baron, F, Battiwalla, M, Beitinjaneh, A, Bejanyan, N, Bhatt, VR, Byrne, M, Cahn, JY, Cairo, M, Castillo, P, Copelan, E, DeFilipp, Z, Perez, MAD, Elsawy, M, Gale, RP, George, B, Grunwald, MR, Hildebrandt, GC, Hogan, WJ, Kanakry, CG, Kansagra, A, Kharfan-Dabaja, MA, Khera, N, Krem, MM, Lazaryan, A, Maakaron, J, Martino, R, McGuirk, J, Michelis, FV, Milone, G, Mishra, A, Murthy, HS, Mussetti, A, Nathan, S, Nishihori, T, Olsson, RF, Palmisiano, N, Patel, S, Saad, A, Seo, S, Sharma, A, Solh, M, Verdonck, LF, Wirk, B, Yared, JA, Litzow, M, Kebriaei, P, Hourigan, CS, Saber, W, Weisdorf, D. An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis. BONE MARROW TRANSPLANTATION. 2021; 56(12)DOI:10.1038/s41409-021-01450-3. PMID:34584240. IF:5.174(Q2/3D).
01/12/2021
Predictors of return to work after autologous stem cell transplantation in patients with multiple myeloma
Granell, M, Senin, A, Barata, A, Cibeira, MT, Gironella, M, Lopez-Pardo, J, Motllo, C, Garcia-Guinon, A, Ben-Azaiz, R, Abella, E, Soler, A, Canet, M, Marti, JM, Martino, R, Sierra, J, de Larrea, CF, Oriol, A, Rosinol, L. Predictors of return to work after autologous stem cell transplantation in patients with multiple myeloma. BONE MARROW TRANSPLANTATION. 2021; 56(12)DOI:10.1038/s41409-021-01429-0. PMID:34404917. IF:5.174(Q2/3D).